We are live on ! Find out more
OCMI

Oaktop Capital Management II Portfolio holdings

AUM $1.34B
1-Year Est. Return 114.5%
This Fund
S&P 500
This Quarter Est. Return
+19.06%
1 Year Est. Return
+114.5%
3 Year Est. Return
+223.73%
5 Year Est. Return
+264.71%
10 Year Est. Return
+1,370.55%
AUM
$648M
AUM Growth
+$80.9M
Cap. Flow
-$15.2M
Cap. Flow %
-2.34%
Top 10 Hldgs %
93.08%
Holding
19
New
–
Increased
–
Reduced
2
Closed
3

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$11.6M
2
PETS icon
PetMed Express
PETS
+$1.39M
3
AXDX
Accelerate Diagnostics
AXDX
+$1.18M
4
ANIK icon
Anika Therapeutics
ANIK
+$566K
5
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
+$487K

Sector Composition

Rank Sector Weight
1 Technology 71.13%
2 Industrials 9.22%
3 Healthcare 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LRCX icon
1
Lam Research
LRCX
$316B
$176M 27.1%
2,952,540
-212,500
-7% -$11.6M
KLAC icon
2
KLA
KLAC
$222B
$132M 20.42%
4,007,500
– –
MXIM
3
DELISTED
Maxim Integrated Products
MXIM
$67.8M 10.46%
742,375
– –
ASPN icon
4
Aspen Aerogels
ASPN
$339M
$59.8M 9.22%
2,939,758
– –
BMY icon
5
Bristol-Myers Squibb
BMY
$129B
$42.9M 6.62%
679,991
– –
CEVA icon
6
CEVA Inc
CEVA
$831M
$35.5M 5.47%
631,377
– –
PRGS icon
7
Progress Software
PRGS
$1.75B
$27M 4.16%
612,526
– –
SONO icon
8
Sonos
SONO
$2.09B
$24.4M 3.76%
650,000
– –
EGAN icon
9
eGain
EGAN
$186M
$24.1M 3.71%
2,536,843
– –
VMW
10
DELISTED
VMware, Inc
VMW
$13.9M 2.15%
92,500
– –
DELL icon
11
Dell
DELL
$239B
$12.4M 1.91%
277,441
– –
PETS icon
12
PetMed Express
PETS
$42.3M
$11.7M 1.81%
333,675
-40,000
-11% -$1.39M
AVGO icon
13
Broadcom
AVGO
$1.76T
$7.42M 1.14%
160,000
– –
GRMN
14
Garmin
GRMN
$56.9B
$6.33M 0.98%
48,000
– –
XLE icon
15
State Street Energy Select Sector SPDR ETF
XLE
$39B
$4.91M 0.76%
200,000
– –
INTC icon
16
Intel
INTC
$413B
$2.11M 0.33%
33,010
– –
ANIK icon
17
Anika Therapeutics
ANIK
$215M
– –
-12,500
Closed -$566K
AXDX
18
DELISTED
Accelerate Diagnostics
AXDX
– –
-15,500
Closed -$1.18M
BMY.RT
19
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
– –
-704,991
Closed -$487K

Similar funds

FFW
Fusion Family Wealth Woodbury, New York $1.34B AUM 18.88% 1-Year Est. Return
NEWAS
N.E.W. Advisory Services De Pere, Wisconsin $1.34B AUM 15.38% 1-Year Est. Return
BFMH
Baring Fintech Manager Holding Castel, Guernsey $1.34B AUM 20.23% 1-Year Est. Return
HAM
HoldCo Asset Management Fort Lauderdale, Florida $1.34B AUM 28.06% 1-Year Est. Return
4WM
49 Wealth Management Austin, Texas $1.34B AUM 12.81% 1-Year Est. Return
WA
WBH Advisory Baltimore, Maryland $1.34B AUM 15.16% 1-Year Est. Return
VHAM
Van Hulzen Asset Management El Dorado Hills, California $1.35B AUM 22.73% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Oaktop Capital Management II's Q1 2021 Portfolio in Review

As of Q1 2021, Oaktop Capital Management II held 19 positions worth $648M, up 14% from $568M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Oaktop Capital Management II's Q1 2021 filing shows 2 reduced and 3 closed positions. The largest sale was Lam Research, an estimated $11.6M.

By sector, the portfolio is most concentrated in Technology at 71% of assets, up from 69% a quarter earlier, followed by Industrials and Healthcare.

  • Oaktop Capital Management II's biggest Q1 2021 reduction was Lam Research, cutting an estimated $11.6M.
  • Oaktop Capital Management II fully exited Accelerate Diagnostics in Q1 2021, selling an estimated $1.18M.
  • Oaktop Capital Management II's ten largest holdings make up 93% of its $648M portfolio in Q1 2021.
  • Oaktop Capital Management II opened 0 new positions and closed 3 in Q1 2021.
  • Oaktop Capital Management II's portfolio value rose 14% quarter-over-quarter to $648M.

Based on Oaktop Capital Management II's 13F filing for Q1 2021, filed 17 May 2021.